New insights into lipid panel indications in Atrial fibrillation

Suhaila  Rayhaan; Hawraa Fadhil  Abbas; Lina Abbas  Hasan; Dhafar Mohamed Hasan Al-Shareefy; Aliaa Ahmed Jasim; Riyam  Hussein; Rana M.  Hameed; Vesen  Atiroğlu; Atheer  Atiroğlu

doi:10.24996/ijs.2026.67.8.2

Authors

Suhaila Rayhaan Department of Biochemistry, College of Medicine, University of Kerbala, Kerbala, Iraq https://orcid.org/0009-0004-9715-2082
Hawraa Fadhil Abbas Department of Biochemistry, College of Medicine, University of Kerbala, Kerbala, Iraq
Lina Abbas Hasan Department of laboratory and clinical science, College of pharmacy, University of Babylon, Babylon, Iraq
Dhafar Mohamed Hasan Al-Shareefy Department of laboratory and clinical science, College of pharmacy, University of Babylon, Babylon, Iraq
Aliaa Ahmed Jasim Department of Clinical Laboratory Sciences, College of Pharmacy, AL-Zahraa University for Women, Karbala, Iraq https://orcid.org/0009-0004-2843-0704
Riyam Hussein Department of laboratory and clinical science, College of pharmacy, University of Babylon, Babylon, Iraq https://orcid.org/0009-0002-7105-4682
Rana M. Hameed Department of Biochemistry, College of Medicine, University of Kerbala, Kerbala, Iraq
Vesen Atiroğlu Sakarya University, Biomaterials, Energy, Photocatalysis, Enzyme Technology, Nano & Advanced Materials, Additive Manufacturing, Environmental Applications and Sustainability Research & Development Group (BIOE N AMS R & D Group), 54187 Sakarya, Turkey / Sakarya University, Biomedical, Magnetic and Semiconductor Materials Application and Research Center (BIMAS-RC), 54187 Sakarya, Turkey
Atheer Atiroğlu Sakarya University, Biomaterials, Energy, Photocatalysis, Enzyme Technology, Nano & Advanced Materials, Additive Manufacturing, Environmental Applications and Sustainability Research & Development Group (BIOE N AMS R & D Group), 54187 Sakarya, Turkey / Sakarya University, Biomedical, Magnetic and Semiconductor Materials Application and Research Center (BIMAS-RC), 54187 Sakarya, Turkey

DOI:

https://doi.org/10.24996/ijs.2026.67.8.2

Keywords:

Atrial fibrillation, AIP, AC, Castelli risk indicators

Abstract

Between February and July 2024, an observational study was carried out at Al-Zahraa Teaching Hospital in Al-Kut, Iraq, in partnership with the University of Kerbala’s College of Medicine. The study enrolled 120 participants (ages 22–90), divided equally into an AF group (n=60) and a control group (n=60). Most atherogenic exhibit the highest mean values in patients with permanent atrial fibrillation (AF), The lowest mean values are typically observed in lone AF patients, suggesting a reduced atherogenic burden. The results also indicate that, regardless of blood pressure stage, a combination of increased TG/HDL ratio may be a good indication of specific atherogenic indices (AIP and CRI-I) in patients with AF. In conclusion, alongside routine monitoring of traditional lipid measures, parameters like AIP, AC, and CRI-I&II should be considered in day-to-day practice.